PT2056825E - Utilização de formulações de opioide em dispositivos de fornecimento de fármaco sem agulha - Google Patents

Utilização de formulações de opioide em dispositivos de fornecimento de fármaco sem agulha

Info

Publication number
PT2056825E
PT2056825E PT78029931T PT07802993T PT2056825E PT 2056825 E PT2056825 E PT 2056825E PT 78029931 T PT78029931 T PT 78029931T PT 07802993 T PT07802993 T PT 07802993T PT 2056825 E PT2056825 E PT 2056825E
Authority
PT
Portugal
Prior art keywords
needle
drug delivery
delivery devices
less drug
opioid formulations
Prior art date
Application number
PT78029931T
Other languages
English (en)
Inventor
Jo Woodward
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PT2056825E publication Critical patent/PT2056825E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PT78029931T 2006-08-29 2007-08-29 Utilização de formulações de opioide em dispositivos de fornecimento de fármaco sem agulha PT2056825E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06119722 2006-08-29

Publications (1)

Publication Number Publication Date
PT2056825E true PT2056825E (pt) 2013-02-15

Family

ID=38089858

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78029931T PT2056825E (pt) 2006-08-29 2007-08-29 Utilização de formulações de opioide em dispositivos de fornecimento de fármaco sem agulha

Country Status (11)

Country Link
US (1) US8987290B2 (pt)
EP (1) EP2056825B1 (pt)
JP (1) JP5306207B2 (pt)
CY (1) CY1113575T1 (pt)
DE (1) DE202006018609U1 (pt)
DK (1) DK2056825T3 (pt)
ES (1) ES2398925T3 (pt)
PL (1) PL2056825T3 (pt)
PT (1) PT2056825E (pt)
SI (1) SI2056825T1 (pt)
WO (1) WO2008025790A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1685839T1 (sl) 1997-12-22 2013-08-30 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
KR20040098050A (ko) 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP2405915B1 (en) 2009-03-10 2018-10-24 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
SG11201407363RA (en) * 2012-04-20 2014-12-30 Smiths Medical Asd Inc Medication dispensers
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
FR3032353B1 (fr) 2015-02-06 2017-03-10 Jacques Seguin Composition pharmaceutique et dispositif pour le traitement de la douleur
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735761A (en) * 1971-02-11 1973-05-29 Ampoules Inc Hypodermic devices
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
SE9201246D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
DE4445969C1 (de) * 1994-12-22 1996-03-14 Schott Glaswerke Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
US5730723A (en) * 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
SI1685839T1 (sl) * 1997-12-22 2013-08-30 Euro-Celtique S.A. Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
US6375957B1 (en) * 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
DE10010123A1 (de) * 2000-03-03 2001-09-20 Boehringer Ingelheim Int Nadelloser Injektor in Miniaturausführung
US6689092B2 (en) * 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
CA2430499C (en) * 2000-11-30 2012-05-22 Biovalve Technologies, Inc. Injection systems
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
WO2002083215A1 (en) * 2001-04-13 2002-10-24 Becton Dickinson And Company Intradermal needle
CN1525851A (zh) * 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
AU2002326661A1 (en) 2001-08-17 2003-03-03 Antares Pharma, Inc. Administration of insulin by jet injection
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
GB2379390B (en) 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
KR20040098050A (ko) * 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
US8236292B2 (en) 2004-06-04 2012-08-07 Camurus Ab Liquid depot formulations
DE102004042581B4 (de) * 2004-09-02 2022-09-15 Ypsomed Ag Auto-Pen für Zweikammerampulle
AU2006210865B2 (en) * 2005-02-01 2008-12-04 Kaleo, Inc. Devices, systems, and methods for medicament delivery
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US20070055200A1 (en) 2005-08-10 2007-03-08 Gilbert Scott J Needle-free jet injection drug delivery device
US9308325B2 (en) * 2006-06-19 2016-04-12 Corium International, Inc. Methods, devices, and kits for microjet drug delivery

Also Published As

Publication number Publication date
EP2056825B1 (en) 2012-11-14
US8987290B2 (en) 2015-03-24
PL2056825T3 (pl) 2013-04-30
JP5306207B2 (ja) 2013-10-02
WO2008025790A2 (en) 2008-03-06
EP2056825A2 (en) 2009-05-13
JP2010501308A (ja) 2010-01-21
ES2398925T3 (es) 2013-03-22
DK2056825T3 (da) 2013-02-04
US20100056554A1 (en) 2010-03-04
SI2056825T1 (sl) 2013-06-28
CY1113575T1 (el) 2016-06-22
DE202006018609U1 (de) 2007-05-16
WO2008025790A3 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
IL276157A (en) Pharmaceutical preparations and methods for transferring them related to them
IL275854A (en) Pharmaceutical composition and its administration
IL250674A0 (en) A compound for administering a drug through the large intestine
PT2056825E (pt) Utilização de formulações de opioide em dispositivos de fornecimento de fármaco sem agulha
IL213376A0 (en) Zaleplon gastroretentive drug delivery system and uses thereof
EP2101745A4 (en) DISTRIBUTION OF MEDICINAL PRODUCTS
EP1978892A4 (en) DEVICE FOR TREATING DRUG DELIVERY
ZA200807006B (en) Drug delivery device
IL183295A0 (en) Drug delivery device
IL207569A0 (en) Compositions and methods for drug delivery
EP1909772A4 (en) TRANSDERMAL DRUG FORMULATION
EP2313122A4 (en) MEDICAL DRUG DELIVERY DEVICE
ZA200903649B (en) Devices and methods for ophthalmic drug delivery
IL195764A0 (en) Compositions and methods for drug delivery
EP2010162A4 (en) COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
EP2150235A4 (en) Capsule formulation coated with nanoparticles for the purpose of dermal drug administration
EP2012705A4 (en) PHARMACEUTICAL FORMULATIONS FOR IONTOPHORETIC ACTIVE INJECTION
GB0613428D0 (en) In situ delivery of probotic formulations
GB0608187D0 (en) Drug Delivery
GB0716003D0 (en) Delivery of drug combinations